A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

Clinical trial NCT07230483 · RECRUITING

Trial details

NCT number: NCT07230483
Sponsor: Keymed Biosciences Co.Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)

Start date: 2025-12-01
Primary completion: 2027-12-01
Enrollment: 246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.